May 21, 2014
A North Carolina federal judge on Wednesday dismissed Reckitt Benckiser Pharmaceuticals Inc.'s suit accusing BioDelivery Sciences International Inc. of infringing a patent for its opiate addiction treatment Suboxone by filing an application for a similar drug, saying the plaintiff's claims were either premature or unsupported.